Merck Serono spinouts

Merck Animal Health

Lancaster R.T., Foxcroft, G.R., Boland, M.R, Edwards, S. and Gordon, I., 1985. Fertility of sows treated with exogenous estradiol and/or gonadotropins to control postweaning estrus. Anim. Reprod. Sci., 8:365-373 In the first of two experiments 28 multiparous sows were allocated to one of the following treatments two days after weaning at approximately 35 days postpartum: (1) untreated; (2) i.m....

ATS Merck CME Newsletter

Charles M. Balch, MD, Professor of Surgery, Oncology and Dermatology, Johns Hopkins Medicine, Baltimore, reviewed the current version of the melanoma staging as well as new data on staging and prognosis contained in the 2008 version of the American Joint Committee on Cancer (AJCC) Melanoma Staging Schema. The final version of the melanoma staging criteria are embargoed until May 2009 and implem...

Sabouraud-chloramphenicol agar: ADSA Micro SDS: Merck Sodium acetate: Merck Sodium azide: Merck Sodium citrate: Merck Sodium laurylsarcosinate: Sigma Sodium taurocholate: Sigma Spurr resin: Sigma Streptomycin sulphate: Sigma Succinic acid: Merck

The Merck Manual, 8th Edition

Achieving venture returns through corporate spinouts

As the biotechnology industry matures, the opportunity arises to establish companies by ‘spinning out’ undervalued but significant assets from larger biotechnology or pharmaceutical parent companies. Recognising the value in such assets and achieving rapid and meaningful returns on investments in corporate spinouts requires the infusion of the operational discipline of start-up companies along ...